ICU Medical Modifies FY18 Guidance - Quick Facts

(RTTNews) - ICU Medical, Inc. (ICUI) modified its full year 2018 guidance of adjusted EBITDA from a range of $270 million to $280 million to a range of $280 million to $290 million and adjusted earnings per share from a range of $8.30 to $8.70 to a range of $8.45 to $8.85. The company also provided initial 2019 adjusted EBITDA guidance in the range of $315 million to $340 million.

Adjusted diluted earnings per share for the third quarter of 2018 were $1.85 as compared to $1.12 for the third quarter of 2017. Also, adjusted EBITDA was $68.4 million for the third quarter of 2018 as compared to $55.4 million for the third quarter of 2017. Third quarter 2018 revenue was $327.2 million, compared to $343.2 million in the same period last year.